Stovek

Catalog Veterinary products

Trividgekt 5%-TRV

download the instructions

Trividgekt 5%-TRV

Description:

Trividgekt 5%-TRV is an antiviral veterinary product.

Dosage form: solution for injection.

Composition:

1 ml contains 50.0 mg of aRNase (1,5-bis- [N, N-1- (4-tetradecyl ) diazoniabicyclo [2.2.2] octyl] pentane tetrobromide), as well as excipients: propylene glycol and benzyl alcohol.

Indications for use:

Trividgekt 5%-TRV is used for therapeutic and prophylactic purposes in animals with infections caused by RNA viruses: pigs - rotavirus diarrhea, porcine respiratory and reproductive syndrome, influenza, enteroviral gastroenteritis of piglets and other infections caused by RNA genomic viruses sensitive to the veterinary product; calves - rotavirus enteritis, parainfluenza-3, respiratory syncytial infection, coronavirus enteritis and other infections caused by RNA genomic viruses sensitive to the veterinary product.

Method of administration and dosage:

The veterinary drug is administered once a day.

Pigs

0.2 ml per 1 kg of body weight. For animals weighing more than 100 kg - 0.1-0.2 ml of the veterinary drug per 1 kg of body weight, but not more than 20 ml at one injection site.

Calves

0.2 ml per 1 kg of body weight. For animals weighing more than 100 kg - 0.1-0.2 ml of the veterinary drug per 1 kg of body weight, but not more than 20 ml at one injection site.

To enhance the therapeutic effect, the administration of the veterinary drug can be repeated after 5-7 days at the same dose.

Pharmaceutical properties

The veterinary drug has a pronounced effect on RNA-containing viruses of the families Paramyxoviridae, Coronaviridae, Arenaviridae, Retroviridae, Picornaviridae, Birnaviridae, Orthomyxoviridae, etc.

The mechanism of action is based on the damage of RNA viral particles using a low molecular weight artificial ribonuclease. High stability to physical and chemical factors, as well as the small size of artificial RNase in comparison with protein molecules, provide high efficiency of antiviral therapy. The small molecular weight of the compound increases the efficiency of penetration of synthetic ribonuclease into the virus capsid.

The veterinary drug is not toxic, no contraindications were found.

The veterinary drug, according to the degree of exposure belongs to low-hazard substances (hazard class 4) according to GOST 12.1.007-76.